Berkshire Sells UnitedHealth Stake, Shares Drop
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 43 minutes ago
0mins
Should l Buy UNH?
Source: Newsfilter
- Stock Volatility: UnitedHealth (UNH) shares fell 3% on Monday after Berkshire Hathaway (BRK) disclosed its stake sale during a portfolio reshuffle in Q1, indicating market uncertainty about the company's future.
- Investor Reaction: Berkshire had previously bought 5 million shares of UnitedHealth in August, boosting its stock price; however, this divestment may trigger profit-taking among investors, especially given that UnitedHealth's stock has risen about 20% this year.
- Management Confidence: UnitedHealth raised its annual profit forecast and exceeded Wall Street expectations for Q1 earnings despite facing challenges like rising healthcare costs and regulatory probes, with CEO Stephen Hemsley working to restore investor confidence.
- Industry Trends: Analysts noted that while Berkshire's stake sale may pressure the stock in the short term, the overall managed care sector showed strong performance in Q1, indicating improved cost management capabilities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 393.850
Low
330.00
Averages
397.82
High
444.00
Current: 393.850
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Berkshire Fully Exits UnitedHealth Stake Amid Strong Recovery
- Berkshire's Exit Dynamics: Berkshire Hathaway sold its entire 5.04 million share position in UnitedHealth (UNH) during Q1, marking a significant shift in investment strategy under new CEO Greg Abel, even as the stock rebounded approximately 45% since February 10.
- Market Reaction Analysis: Despite Berkshire's exit prompting intense discussions among retail traders, many argued that the firm sold between $250 and $290, missing the opportunity for a strong rebound, reflecting ongoing concerns about Medicare reimbursement pressures.
- UnitedHealth's Strong Recovery: UNH closed at $270.59 at the end of Q1 and surged thereafter due to strong earnings and improved reimbursement rates, becoming one of the best-performing components in the Dow Jones Industrial Average, indicating optimistic market sentiment about its future prospects.
- AI Investment Strategy: UnitedHealth plans to invest $1.5 billion in AI in 2023, having already deployed over 1,000 AI use cases internally, which is expected to enhance operational efficiency and automation, positioning the company as a leader in the healthcare industry.
See More
Berkshire Sells UnitedHealth Stake, Shares Drop
- Stock Volatility: UnitedHealth (UNH) shares fell 3% on Monday after Berkshire Hathaway (BRK) disclosed its stake sale during a portfolio reshuffle in Q1, indicating market uncertainty about the company's future.
- Investor Reaction: Berkshire had previously bought 5 million shares of UnitedHealth in August, boosting its stock price; however, this divestment may trigger profit-taking among investors, especially given that UnitedHealth's stock has risen about 20% this year.
- Management Confidence: UnitedHealth raised its annual profit forecast and exceeded Wall Street expectations for Q1 earnings despite facing challenges like rising healthcare costs and regulatory probes, with CEO Stephen Hemsley working to restore investor confidence.
- Industry Trends: Analysts noted that while Berkshire's stake sale may pressure the stock in the short term, the overall managed care sector showed strong performance in Q1, indicating improved cost management capabilities.
See More
Trump Warns Iran of Possible Conflict Resurgence
- Oil Price Surge: Trump's social media comments urging Iran to 'get moving' have led to a spike in oil prices overnight, raising concerns about a potential resurgence of conflict that could destabilize global energy markets.
- Market Volatility: Following Trump's remarks, stock futures have fallen, setting Wall Street up for another day of significant losses, highlighting the direct impact of political factors on market sentiment.
- Delta Air Lines Investment: Berkshire Hathaway's announcement of a $2.6 billion stake in Delta Air Lines, making it the company's 14th largest holding, reflects confidence in the airline industry's recovery and may drive Delta's stock price higher.
- Meta Layoff Plans: Meta is expected to lay off about 10% of its workforce this week, amidst widespread layoffs in the tech sector, which could dampen employee morale and underscores the company's urgent need for cost control.
See More
Berkshire Exits UnitedHealth Stake, Shares Drop
- Stock Price Decline: UnitedHealth Group (UNH) fell by 5.3% in premarket trading on Monday after Berkshire Hathaway (BRK.A, BRK.B) disclosed its exit from the health insurer, indicating market concerns about the company's future prospects.
- Historical Stake Changes: Berkshire first acquired UnitedHealth shares in Q4 2006 and has since adjusted its position multiple times, most recently re-entering in Q2 2025 with approximately 5.04 million shares, reflecting fluctuating confidence in the company.
- Market Performance: UnitedHealth's stock traded between $255 and $358 in Q1 2026, down 18% year-over-year, but rebounded sharply in the following weeks after strong Q1 earnings and optimistic guidance pushed shares toward the $400 mark.
- Investor Sentiment: Despite a year-to-date gain of about 19%, making it one of the stronger Dow components, Berkshire's exit may dampen investor confidence in UnitedHealth's growth potential, especially after the stock reached a 52-week high of $404.14.
See More
Nvidia Earnings in Focus as Market Reacts Mutedly
- Nvidia Earnings Expectations: Nvidia is expected to report an 80% year-over-year revenue growth for Q1, with its market cap briefly exceeding $5.7 trillion last week, underscoring its leadership in the AI sector, despite a 4.4% drop in stock price last Friday.
- Market Impact Analysis: Analysts note that Nvidia accounts for 9% of the S&P 500 index and contributed 20% to the index's total returns for 2026, highlighting its significant influence on overall market performance, particularly driven by AI stocks.
- Retail Earnings Outlook: TJX anticipates a 6% year-over-year revenue increase for Q1, while Walmart is expected to maintain strong performance following a 12% EPS growth, indicating continued consumer spending resilience.
- Berkshire Portfolio Adjustments: Berkshire Hathaway, under new CEO Abel, acquired a $2.6 billion stake in Delta Air Lines and reduced investments in banking and healthcare sectors, reflecting a strategy focused on concentrated investments.
See More
Major Premarket Stock Movements in Key Companies
- Regeneron Drug Trial Failure: Regeneron Pharmaceuticals saw its stock plummet over 11% after its skin cancer treatment failed to meet goals in a late-stage trial, potentially undermining investor confidence and future R&D funding.
- Macy's Stock Surge: Macy's shares jumped nearly 4% in premarket trading after a regulatory filing revealed that Berkshire Hathaway initiated a small position valued at approximately $55 million, raising speculation about investment lieutenant Ted Weschler's involvement.
- Dominion Energy Acquisition News: Dominion Energy's stock surged more than 12% following NextEra Energy's announcement of an all-stock acquisition deal, which is expected to create the world's largest regulated electric utility, significantly enhancing market presence.
- Bio Rad Laboratories Stock Spike: Bio Rad Laboratories' shares rose 13% after a Wall Street Journal report indicated that activist investor Elliott Investment Management has built a sizable stake in the company, although the exact size and Elliott's strategic vision remain undisclosed.
See More
Berkshire Fully Exits UnitedHealth Stake Amid Strong Recovery
- Berkshire's Exit Dynamics: Berkshire Hathaway sold its entire 5.04 million share position in UnitedHealth (UNH) during Q1, marking a significant shift in investment strategy under new CEO Greg Abel, even as the stock rebounded approximately 45% since February 10.
- Market Reaction Analysis: Despite Berkshire's exit prompting intense discussions among retail traders, many argued that the firm sold between $250 and $290, missing the opportunity for a strong rebound, reflecting ongoing concerns about Medicare reimbursement pressures.
- UnitedHealth's Strong Recovery: UNH closed at $270.59 at the end of Q1 and surged thereafter due to strong earnings and improved reimbursement rates, becoming one of the best-performing components in the Dow Jones Industrial Average, indicating optimistic market sentiment about its future prospects.
- AI Investment Strategy: UnitedHealth plans to invest $1.5 billion in AI in 2023, having already deployed over 1,000 AI use cases internally, which is expected to enhance operational efficiency and automation, positioning the company as a leader in the healthcare industry.
See More
Berkshire Sells UnitedHealth Stake, Shares Drop
- Stock Volatility: UnitedHealth (UNH) shares fell 3% on Monday after Berkshire Hathaway (BRK) disclosed its stake sale during a portfolio reshuffle in Q1, indicating market uncertainty about the company's future.
- Investor Reaction: Berkshire had previously bought 5 million shares of UnitedHealth in August, boosting its stock price; however, this divestment may trigger profit-taking among investors, especially given that UnitedHealth's stock has risen about 20% this year.
- Management Confidence: UnitedHealth raised its annual profit forecast and exceeded Wall Street expectations for Q1 earnings despite facing challenges like rising healthcare costs and regulatory probes, with CEO Stephen Hemsley working to restore investor confidence.
- Industry Trends: Analysts noted that while Berkshire's stake sale may pressure the stock in the short term, the overall managed care sector showed strong performance in Q1, indicating improved cost management capabilities.
See More
Trump Warns Iran of Possible Conflict Resurgence
- Oil Price Surge: Trump's social media comments urging Iran to 'get moving' have led to a spike in oil prices overnight, raising concerns about a potential resurgence of conflict that could destabilize global energy markets.
- Market Volatility: Following Trump's remarks, stock futures have fallen, setting Wall Street up for another day of significant losses, highlighting the direct impact of political factors on market sentiment.
- Delta Air Lines Investment: Berkshire Hathaway's announcement of a $2.6 billion stake in Delta Air Lines, making it the company's 14th largest holding, reflects confidence in the airline industry's recovery and may drive Delta's stock price higher.
- Meta Layoff Plans: Meta is expected to lay off about 10% of its workforce this week, amidst widespread layoffs in the tech sector, which could dampen employee morale and underscores the company's urgent need for cost control.
See More
Berkshire Exits UnitedHealth Stake, Shares Drop
- Stock Price Decline: UnitedHealth Group (UNH) fell by 5.3% in premarket trading on Monday after Berkshire Hathaway (BRK.A, BRK.B) disclosed its exit from the health insurer, indicating market concerns about the company's future prospects.
- Historical Stake Changes: Berkshire first acquired UnitedHealth shares in Q4 2006 and has since adjusted its position multiple times, most recently re-entering in Q2 2025 with approximately 5.04 million shares, reflecting fluctuating confidence in the company.
- Market Performance: UnitedHealth's stock traded between $255 and $358 in Q1 2026, down 18% year-over-year, but rebounded sharply in the following weeks after strong Q1 earnings and optimistic guidance pushed shares toward the $400 mark.
- Investor Sentiment: Despite a year-to-date gain of about 19%, making it one of the stronger Dow components, Berkshire's exit may dampen investor confidence in UnitedHealth's growth potential, especially after the stock reached a 52-week high of $404.14.
See More
Nvidia Earnings in Focus as Market Reacts Mutedly
- Nvidia Earnings Expectations: Nvidia is expected to report an 80% year-over-year revenue growth for Q1, with its market cap briefly exceeding $5.7 trillion last week, underscoring its leadership in the AI sector, despite a 4.4% drop in stock price last Friday.
- Market Impact Analysis: Analysts note that Nvidia accounts for 9% of the S&P 500 index and contributed 20% to the index's total returns for 2026, highlighting its significant influence on overall market performance, particularly driven by AI stocks.
- Retail Earnings Outlook: TJX anticipates a 6% year-over-year revenue increase for Q1, while Walmart is expected to maintain strong performance following a 12% EPS growth, indicating continued consumer spending resilience.
- Berkshire Portfolio Adjustments: Berkshire Hathaway, under new CEO Abel, acquired a $2.6 billion stake in Delta Air Lines and reduced investments in banking and healthcare sectors, reflecting a strategy focused on concentrated investments.
See More
Major Premarket Stock Movements in Key Companies
- Regeneron Drug Trial Failure: Regeneron Pharmaceuticals saw its stock plummet over 11% after its skin cancer treatment failed to meet goals in a late-stage trial, potentially undermining investor confidence and future R&D funding.
- Macy's Stock Surge: Macy's shares jumped nearly 4% in premarket trading after a regulatory filing revealed that Berkshire Hathaway initiated a small position valued at approximately $55 million, raising speculation about investment lieutenant Ted Weschler's involvement.
- Dominion Energy Acquisition News: Dominion Energy's stock surged more than 12% following NextEra Energy's announcement of an all-stock acquisition deal, which is expected to create the world's largest regulated electric utility, significantly enhancing market presence.
- Bio Rad Laboratories Stock Spike: Bio Rad Laboratories' shares rose 13% after a Wall Street Journal report indicated that activist investor Elliott Investment Management has built a sizable stake in the company, although the exact size and Elliott's strategic vision remain undisclosed.
See More
